Stratos Wealth Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Stratos Wealth Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,074	Closed	-$202K	–	1122
2020 Q3	$202K	Buy	2,074 +90	+5%	+$10.4K	0.01%	919
2020 Q2	$243K	Buy	+1,984	New	+$225K	0.01%	835
2020 Q1	–	Sell	-2,628	Closed	-$275K	–	1060
2019 Q4	$275K	Sell	2,628 -499	-16%	-$56K	0.01%	783
2019 Q3	$360K	Buy	3,127 +1,082	+53%	+$164K	0.02%	665
2019 Q2	$353K	Buy	2,045 +117	+6%	+$20.2K	0.02%	673
2019 Q1	$325K	Buy	+1,928	New	+$287K	0.01%	683
2018 Q4	–	Sell	-2,197	Closed	-$380K	–	2799
2018 Q3	$380K	Buy	2,197 +215	+11%	+$31K	0.02%	625
2018 Q2	$277K	Buy	1,982 +1,034	+109%	+$147K	0.01%	780
2018 Q1	$107K	Buy	948 +648	+216%	+$81.5K	﹤0.01%	1165
2017 Q4	$40K	Buy	+300	New	+$35.3K	﹤0.01%	1632

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stratos Wealth Partners's GWPH Position: Q4 2020 in Review

Stratos Wealth Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 2,074 shares — an estimated $202K sold.

Stratos Wealth Partners first reported a position in GWPH in Q4 2017 and held it in 10 quarters. The position peaked at $380K in Q3 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Stratos Wealth Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Stratos Wealth Partners sold 2,074 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $202K.
Stratos Wealth Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 10 quarters.
Stratos Wealth Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $380K in Q3 2018.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Stratos Wealth Partners's 13F filing for Q4 2020, filed 29 Jan 2021.